As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
India’s powerful copycat pharmaceutical industry is set to roll out generic weight-loss drugs in the UK within weeks, with one leading producer forecasting a “huge price war t ...
The future of the weight loss market might not revolve around GLP-1 drugs.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback